Infections in patients with multiple sclerosis treating with disease-modifying therapies: a risk assessment cohort study

被引：0
|
作者：
Fattahi, M. R. [1 ]
Sahraian, M. A. [1 ]
Mesgarof, M. A. [1 ]
Valizadeh, A. [1 ]
Azimi, A. [1 ]
Moghadasi, A. N. [1 ]
Doosti, R. [1 ]
Hemmati, Z. [2 ]
Abouzari, F. [3 ]
Ghashti, S. Hamtaei [1 ]
机构：
[1] Univ Tehran Med Sci, Neurol, Tehran, Iran
[2] Univ Tehran Med Sci, Nursing & Midwifery Care, Tehran, Iran
[3] Univ Tehran Med Sci, Psychol, Tehran, Iran
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1092
引用
收藏
页码：866 / 867
页数：2
相关论文
共 50 条
  • [31] Cancer risk for multiple sclerosis patients treated with azathioprine and disease-modifying therapies: an Italian observational study
    La Mantia, Loredana
    Benedetti, Maria Donata
    Sant, Milena
    d'Arma, Alessia
    Di Tella, Sonia
    Lillini, Roberto
    Mendozzi, Laura
    Marangi, Antonio
    Turatti, Marco
    Caputo, Domenico
    Rovaris, Marco
    NEUROLOGICAL SCIENCES, 2021, 42 (12) : 5157 - 5163
  • [32] Infections in patients with multiple sclerosis: Implications for disease-modifying therapy
    Celius, E. G.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 : 34 - 36
  • [33] Assessment of the risk of severe COVID19 associated with disease-modifying multiple sclerosis therapies in treated patients
    Bordet, C.
    Kolla, E.
    Desplas, D.
    Botton, J.
    Zureik, M.
    Grimaldi, L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 147 - 147
  • [34] Effects of disease-modifying therapies on lipid parameters in patients with multiple sclerosis
    Koca, Nizameddin
    Seferoglu, Meral
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 77
  • [35] Audit of patients switching disease-modifying therapies for the treatment of multiple sclerosis
    Embrey, NH
    Woolmore, JA
    Hawkins, CP
    MULTIPLE SCLEROSIS, 2005, 11 : S159 - S159
  • [36] The influence of disease-modifying therapies on gut microbiota in patients with multiple sclerosis
    Flaskamp, Martina
    Andlauer, Till
    Uibel, Paula
    Held, Friederike
    Jud, Sarah
    Troci, Alba
    Afzali, Ali
    Gasperi, Christiane
    Giglhuber, Katrin
    Strauss, Eva-Maria
    Berthele, Achim
    Bang, Corinna
    Franke, Andre
    Hemmer, Bernhard
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 328 - 328
  • [37] Adherence to disease-modifying therapies and attitudes regarding disease in patients with multiple sclerosis
    Ozura, Ana
    Kovac, Lea
    Sega, Sasa
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 : S6 - S11
  • [38] Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
    Lee, Chi-Yan
    Chan, Koon-Ho
    PHARMACEUTICS, 2024, 16 (01)
  • [39] Economics of Multiple Sclerosis Disease-Modifying Therapies in the USA
    Daniel M. Hartung
    Current Neurology and Neuroscience Reports, 2021, 21
  • [40] Disease-modifying therapies in Chinese children with multiple sclerosis
    Yang, Fen
    Huang, De-hui
    Yang, Yang
    Wu, Wei-ping
    TURKISH JOURNAL OF PEDIATRICS, 2014, 56 (05) : 482 - 486
12345